Kronos Worldwide Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Kronos Worldwide Inc. on June 11, 2012, covering events occurring on June 8, 2012. The filing primarily addresses corporate governance changes and the dissemination of a press release.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on non-financial corporate events rather than financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size from seven to eight members effective June 8, 2012.
- New Director Appointment: Kern Wildenthal, M.D., Ph.D., was elected to fill the newly created vacancy. He was appointed to serve on the Audit Committee and the Management Development and Compensation Committee.
- Compensation Grant: Dr. Wildenthal was granted 1,000 shares of common stock (par value $0.01) pursuant to the standard formula used for annual director grants.
Guidance, Outlook, and Risks
The registrant furnished a press release dated June 11, 2012, under Item 7.01 (Regulation FD Disclosure). The content of this press release is incorporated by reference as Exhibit 99.1. The filing explicitly states that the information in Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. No specific guidance, outlook, or risk factors are detailed within the body of this 8-K text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated June 11, 2012) for the specific details of the Regulation FD disclosure.
- Verify the biographical background and potential conflicts of interest for the newly appointed director, Dr. Kern Wildenthal.
- Confirm the impact of the board expansion on committee quorum and voting dynamics.